E-2730 | m-entrepreneurship.com

Product Name :
E-2730

Search keywords :
E2730

drugId :
null

Target Vo:
GABA transporter 1

Target Vo Short Name :
GAT1

Moa_Name:
Synaptic transmission modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Eisai Inc

Active Indication_Name:

In Active Indication_Name:
Epilepsy, Reflex

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CDC37 Antibody
CIDEC/FSP27 Antibody
USP7 Antibody (YA657): USP7 Antibody (YA657) is a non-conjugated and Mouse origined monoclonal antibody about 128 kDa, targeting to USP7 (3E4). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts